BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33436868)

  • 1. Sterol auto-oxidation adversely affects human motor neuron viability and is a neuropathological feature of amyotrophic lateral sclerosis.
    Dodge JC; Yu J; Sardi SP; Shihabuddin LS
    Sci Rep; 2021 Jan; 11(1):803. PubMed ID: 33436868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutral Lipid Cacostasis Contributes to Disease Pathogenesis in Amyotrophic Lateral Sclerosis.
    Dodge JC; Jensen EH; Yu J; Sardi SP; Bialas AR; Taksir TV; Bangari DS; Shihabuddin LS
    J Neurosci; 2020 Nov; 40(47):9137-9147. PubMed ID: 33051352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
    Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
    Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deletion of
    Dermentzaki G; Politi KA; Lu L; Mishra V; Pérez-Torres EJ; Sosunov AA; McKhann GM; Lotti F; Shneider NA; Przedborski S
    eNeuro; 2019; 6(1):. PubMed ID: 30815534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
    Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
    Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
    Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voltage-gated calcium channels are abnormal in cultured spinal motoneurons in the G93A-SOD1 transgenic mouse model of ALS.
    Chang Q; Martin LJ
    Neurobiol Dis; 2016 Sep; 93():78-95. PubMed ID: 27151771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
    Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
    Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting the Sigma-1 Receptor via Pridopidine Ameliorates Central Features of ALS Pathology in a SOD1
    Ionescu A; Gradus T; Altman T; Maimon R; Saraf Avraham N; Geva M; Hayden M; Perlson E
    Cell Death Dis; 2019 Mar; 10(3):210. PubMed ID: 30824685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-vivo genetic ablation of metabotropic glutamate receptor type 5 slows down disease progression in the SOD1
    Bonifacino T; Provenzano F; Gallia E; Ravera S; Torazza C; Bossi S; Ferrando S; Puliti A; Van Den Bosch L; Bonanno G; Milanese M
    Neurobiol Dis; 2019 Sep; 129():79-92. PubMed ID: 31102766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS.
    Luisier R; Tyzack GE; Hall CE; Mitchell JS; Devine H; Taha DM; Malik B; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
    Nat Commun; 2018 May; 9(1):2010. PubMed ID: 29789581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing the multiple roles of FGF-2 in SOD1
    Kefalakes E; Böselt S; Sarikidi A; Ettcheto M; Bursch F; Naujock M; Stanslowsky N; Schmuck M; Barenys M; Wegner F; Grothe C; Petri S
    J Cell Physiol; 2019 May; 234(5):7395-7410. PubMed ID: 30370540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The distribution and function of GDE2, a regulator of spinal motor neuron survival, are disrupted in Amyotrophic Lateral Sclerosis.
    Westerhaus A; Joseph T; Meyers AJ; Jang Y; Na CH; Cave C; Sockanathan S
    Acta Neuropathol Commun; 2022 May; 10(1):73. PubMed ID: 35550203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The vulnerability of spinal motoneurons and soma size plasticity in a mouse model of amyotrophic lateral sclerosis.
    Dukkipati SS; Garrett TL; Elbasiouny SM
    J Physiol; 2018 May; 596(9):1723-1745. PubMed ID: 29502344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Astrocytes drive upregulation of the multidrug resistance transporter ABCB1 (P-Glycoprotein) in endothelial cells of the blood-brain barrier in mutant superoxide dismutase 1-linked amyotrophic lateral sclerosis.
    Qosa H; Lichter J; Sarlo M; Markandaiah SS; McAvoy K; Richard JP; Jablonski MR; Maragakis NJ; Pasinelli P; Trotti D
    Glia; 2016 Aug; 64(8):1298-313. PubMed ID: 27158936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connexin 43 in astrocytes contributes to motor neuron toxicity in amyotrophic lateral sclerosis.
    Almad AA; Doreswamy A; Gross SK; Richard JP; Huo Y; Haughey N; Maragakis NJ
    Glia; 2016 Jul; 64(7):1154-69. PubMed ID: 27083773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the NAD
    Harlan BA; Killoy KM; Pehar M; Liu L; Auwerx J; Vargas MR
    Exp Neurol; 2020 May; 327():113219. PubMed ID: 32014438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting low levels of MIF expression as a potential therapeutic strategy for ALS.
    Alfahel L; Gschwendtberger T; Kozareva V; Dumas L; Gibbs R; Kertser A; Baruch K; Zaccai S; Kahn J; Thau-Habermann N; Eggenschwiler R; Sterneckert J; Hermann A; Sundararaman N; Vaibhav V; Van Eyk JE; Rafuse VF; Fraenkel E; Cantz T; Petri S; Israelson A
    Cell Rep Med; 2024 May; 5(5):101546. PubMed ID: 38703766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.